|
US3312711A
(en)
|
1964-10-01 |
1967-04-04 |
Monsanto Res Corp |
Aryloxy esters of pyridine and furan aliphatic acids
|
|
US3674836A
(en)
|
1968-05-21 |
1972-07-04 |
Parke Davis & Co |
2,2-dimethyl-{11 -aryloxy-alkanoic acids and salts and esters thereof
|
|
US4027009A
(en)
|
1973-06-11 |
1977-05-31 |
Merck & Co., Inc. |
Compositions and methods for depressing blood serum cholesterol
|
|
JPS5612114B2
(en)
|
1974-06-07 |
1981-03-18 |
|
|
|
US4231938A
(en)
|
1979-06-15 |
1980-11-04 |
Merck & Co., Inc. |
Hypocholesteremic fermentation products and process of preparation
|
|
MX7065E
(en)
|
1980-06-06 |
1987-04-10 |
Sankyo Co |
A MICROBIOLOGICAL PROCEDURE FOR PREPARING DERIVATIVES OF ML-236B
|
|
US4450171A
(en)
|
1980-08-05 |
1984-05-22 |
Merck & Co., Inc. |
Antihypercholesterolemic compounds
|
|
US4448784A
(en)
|
1982-04-12 |
1984-05-15 |
Hoechst-Roussel Pharmaceuticals, Inc. |
1-(Aminoalkylphenyl and aminoalkylbenzyl)-indoles and indolines and analgesic method of use thereof
|
|
US4499289A
(en)
|
1982-12-03 |
1985-02-12 |
G. D. Searle & Co. |
Octahydronapthalenes
|
|
JPS6051189A
(en)
|
1983-08-30 |
1985-03-22 |
Sankyo Co Ltd |
Thiazolidine derivative and its preparation
|
|
CA1327360C
(en)
|
1983-11-14 |
1994-03-01 |
William F. Hoffman |
Oxo-analogs of mevinolin-like antihypercholesterolemic agents
|
|
US4613610A
(en)
|
1984-06-22 |
1986-09-23 |
Sandoz Pharmaceuticals Corp. |
Cholesterol biosynthesis inhibiting pyrazole analogs of mevalonolactone and its derivatives
|
|
US4686237A
(en)
|
1984-07-24 |
1987-08-11 |
Sandoz Pharmaceuticals Corp. |
Erythro-(E)-7-[3'-C1-3 alkyl-1'-(3",5"-dimethylphenyl)naphth-2'-yl]-3,5-dihydroxyhept-6-enoic acids and derivatives thereof
|
|
US4647576A
(en)
|
1984-09-24 |
1987-03-03 |
Warner-Lambert Company |
Trans-6-[2-(substitutedpyrrol-1-yl)alkyl]-pyran-2-one inhibitors of cholesterol synthesis
|
|
HU198005B
(en)
|
1984-12-04 |
1989-07-28 |
Sandoz Ag |
Process for producing mevqlolakton, derivatives, its indene-analogues and pharmaceutical compositions containing them
|
|
US4668794A
(en)
|
1985-05-22 |
1987-05-26 |
Sandoz Pharm. Corp. |
Intermediate imidazole acrolein analogs
|
|
AU598775B2
(en)
|
1985-10-25 |
1990-07-05 |
Sandoz Ag |
Heterocyclic analogs of mevalonolactone
|
|
FR2596393B1
(en)
|
1986-04-01 |
1988-06-03 |
Sanofi Sa |
HYDROXY-3 DIHYDROXYOXOPHOSPHORIO-4 BUTANOIC ACID DERIVATIVES, THEIR PREPARATION PROCESS, THEIR USE AS MEDICAMENTS AND THE COMPOSITIONS CONTAINING THEM
|
|
DK277488A
(en)
|
1987-05-22 |
1988-11-23 |
Squibb & Sons Inc |
PHOSPHORUS HMG-COA REDUCTASE INHIBITORS, THEIR USE AND MANUFACTURING AND INTERMEDIATE PRODUCTS IN THE PREPARATION
|
|
US4759923A
(en)
|
1987-06-25 |
1988-07-26 |
Hercules Incorporated |
Process for lowering serum cholesterol using poly(diallylmethylamine) derivatives
|
|
US4924024A
(en)
|
1988-01-11 |
1990-05-08 |
E. R. Squibb & Sons, Inc. |
Phosphorus-containing squalene synthetase inhibitors, new intermediates and method
|
|
US4871721A
(en)
|
1988-01-11 |
1989-10-03 |
E. R. Squibb & Sons, Inc. |
Phosphorus-containing squalene synthetase inhibitors
|
|
US5506219A
(en)
|
1988-08-29 |
1996-04-09 |
E. R. Squibb & Sons, Inc. |
Pyridine anchors for HMG-CoA reductase inhibitors
|
|
US5753675A
(en)
|
1989-03-03 |
1998-05-19 |
Novartis Pharmaceuticals Corporation |
Quinoline analogs of mevalonolactone and derivatives thereof
|
|
JPH035988A
(en)
|
1989-06-01 |
1991-01-11 |
Matsushita Electric Ind Co Ltd |
dynamic memory
|
|
US5470845A
(en)
|
1992-10-28 |
1995-11-28 |
Bristol-Myers Squibb Company |
Methods of using α-phosphonosulfonate squalene synthetase inhibitors including the treatment of atherosclerosis and hypercholesterolemia
|
|
CA2102591C
(en)
|
1992-11-12 |
2000-12-26 |
Kenji Tsujihara |
Hypoglycemic agent
|
|
US5731292A
(en)
|
1992-11-12 |
1998-03-24 |
Tanabe Seiyaku Co., Ltd. |
Dihydrochalcone derivatives which are hypoglycemic agents
|
|
LT3300B
(en)
|
1992-12-23 |
1995-06-26 |
Schering Corp |
Combination of a cholesterol biosynhtesis inhibitor and a beta- lactam cholesterol absorbtion inhibitor
|
|
US5594016A
(en)
|
1992-12-28 |
1997-01-14 |
Mitsubishi Chemical Corporation |
Naphthalene derivatives
|
|
US5776983A
(en)
|
1993-12-21 |
1998-07-07 |
Bristol-Myers Squibb Company |
Catecholamine surrogates useful as β3 agonists
|
|
US5488064A
(en)
|
1994-05-02 |
1996-01-30 |
Bristol-Myers Squibb Company |
Benzo 1,3 dioxole derivatives
|
|
JP2814950B2
(en)
|
1994-05-11 |
1998-10-27 |
田辺製薬株式会社 |
Hypoglycemic agent
|
|
US5830873A
(en)
|
1994-05-11 |
1998-11-03 |
Tanabe Seiyaku Co., Ltd. |
Propiophenone derivative and a process for preparing the same
|
|
US5612359A
(en)
|
1994-08-26 |
1997-03-18 |
Bristol-Myers Squibb Company |
Substituted biphenyl isoxazole sulfonamides
|
|
US5491134A
(en)
|
1994-09-16 |
1996-02-13 |
Bristol-Myers Squibb Company |
Sulfonic, phosphonic or phosphiniic acid β3 agonist derivatives
|
|
US5541204A
(en)
|
1994-12-02 |
1996-07-30 |
Bristol-Myers Squibb Company |
Aryloxypropanolamine β 3 adrenergic agonists
|
|
US5698527A
(en)
|
1995-08-08 |
1997-12-16 |
Merck & Co., Inc. |
Steroidal glycosides as antihyperlipidemic agents
|
|
JP3034192B2
(en)
|
1995-11-07 |
2000-04-17 |
田辺製薬株式会社 |
Propiophenone derivatives and their production
|
|
JP3059088B2
(en)
|
1995-11-07 |
2000-07-04 |
田辺製薬株式会社 |
Propiophenone derivatives and their production
|
|
JP3006513B2
(en)
|
1995-11-07 |
2000-02-07 |
田辺製薬株式会社 |
Pharmaceutical composition
|
|
JP3065235B2
(en)
|
1995-11-07 |
2000-07-17 |
田辺製薬株式会社 |
Propiophenone derivatives and their production
|
|
JP2000502086A
(en)
|
1995-12-13 |
2000-02-22 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
Nuclear receptor ligands and ligand binding domains
|
|
US5770615A
(en)
|
1996-04-04 |
1998-06-23 |
Bristol-Myers Squibb Company |
Catecholamine surrogates useful as β3 agonists
|
|
DE19622222A1
(en)
|
1996-06-03 |
1997-12-04 |
Hoechst Ag |
Use of sodium=proton exchange inhibitor
|
|
WO1997048701A1
(en)
|
1996-06-20 |
1997-12-24 |
Pfizer Inc. |
4,1-benzoxazepines or 4,1-benzothiazepines and their use as squalene synthetase inhibitors
|
|
HRP970330B1
(en)
|
1996-07-08 |
2004-06-30 |
Bayer Ag |
Cycloalkano pyridines
|
|
ATE216704T1
(en)
|
1996-12-26 |
2002-05-15 |
Tanabe Seiyaku Co |
PROPIOPHENONE DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF
|
|
TW536540B
(en)
|
1997-01-30 |
2003-06-11 |
Bristol Myers Squibb Co |
Endothelin antagonists: N-[[2'-[[(4,5-dimethyl-3-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]-2-yl]methyl]-N,3,3-trimethylbutanamide and N-(4,5-dimethyl-3-isoxazolyl)-2'-[(3,3-dimethyl-2-oxo-1-pyrrolidinyl)methyl]-4'-(2-oxazolyl)[1,1'-biphe
|
|
JPH10245391A
(en)
|
1997-03-03 |
1998-09-14 |
Dainippon Ink & Chem Inc |
A therapeutic agent for diabetes containing a 7-glycosyloxybenzopyran derivative as an active ingredient
|
|
GB9713739D0
(en)
|
1997-06-27 |
1997-09-03 |
Karobio Ab |
Thyroid receptor ligands
|
|
ATE267814T1
(en)
|
1997-10-08 |
2004-06-15 |
Sankyo Co |
SUBSTITUTED CONDENSED HETEROCYCLIC COMPOUNDS
|
|
EP1052994A2
(en)
|
1998-02-02 |
2000-11-22 |
Trustees Of Tufts College |
Use of dipeptidylpetidase inhibitors to regulate glucose metabolism
|
|
EP1062222A1
(en)
|
1998-03-09 |
2000-12-27 |
Fondatech Benelux N.V. |
Serine peptidase modulators
|
|
DE19823831A1
(en)
|
1998-05-28 |
1999-12-02 |
Probiodrug Ges Fuer Arzneim |
New pharmaceutical use of isoleucyl thiazolidide and its salts
|
|
DE19828114A1
(en)
|
1998-06-24 |
2000-01-27 |
Probiodrug Ges Fuer Arzneim |
Produgs of unstable inhibitors of dipeptidyl peptidase IV
|
|
DE19828113A1
(en)
|
1998-06-24 |
2000-01-05 |
Probiodrug Ges Fuer Arzneim |
Prodrugs of Dipeptidyl Peptidase IV Inhibitors
|
|
ID26984A
(en)
|
1998-07-06 |
2001-02-22 |
Bristol Myers Squibb Co |
SULFONAMIDE COMPOUNDS AS DOUBLE ENDOTELINE ANGIOTENSIN RECEPTOR ANTAGONISTS
|
|
AU5612199A
(en)
|
1998-09-10 |
2000-04-03 |
Forbes Medi-Tech Inc. |
Compositions comprising one or more phytosterols, phytostanols or mixtures of both and one or more alpha, beta, delta, or gamma tocotrienols or derivatives thereof and use of the compositions in treating or preventing cardiovascular disease, its underlying conditions and other
|
|
US6147089A
(en)
|
1998-09-17 |
2000-11-14 |
Pfizer Inc. |
Annulated 4-carboxyamino-2-methyl-1,2,3,4,-tetrahydroquinolines
|
|
AU767245B2
(en)
|
1998-11-25 |
2003-11-06 |
Nutri Pharma Asa |
Composition comprising soy protein, dietary fibres and a phytoestrogen compound and use thereof in the prevention and/or treatment of cardiovascular diseases
|
|
AU2157400A
(en)
|
1998-12-23 |
2000-07-31 |
G.D. Searle & Co. |
Combinations of cholesteryl ester transfer protein inhibitors and hmg coa reductase inhibitors for cardiovascular indications
|
|
GB9828442D0
(en)
|
1998-12-24 |
1999-02-17 |
Karobio Ab |
Novel thyroid receptor ligands and method II
|
|
CA2362549A1
(en)
|
1999-02-24 |
2000-08-31 |
John Hopkins University |
Compositions and methods for modulating serum cholesterol
|
|
US6548529B1
(en)
|
1999-04-05 |
2003-04-15 |
Bristol-Myers Squibb Company |
Heterocyclic containing biphenyl aP2 inhibitors and method
|
|
US6414002B1
(en)
|
1999-09-22 |
2002-07-02 |
Bristol-Myers Squibb Company |
Substituted acid derivatives useful as antidiabetic and antiobesity agents and method
|
|
US6515117B2
(en)
*
|
1999-10-12 |
2003-02-04 |
Bristol-Myers Squibb Company |
C-aryl glucoside SGLT2 inhibitors and method
|
|
US6432156B1
(en)
|
1999-11-17 |
2002-08-13 |
The Homestead Corp. |
Method of coating materials and materials formed thereby
|
|
US6395767B2
(en)
|
2000-03-10 |
2002-05-28 |
Bristol-Myers Squibb Company |
Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method
|
|
US6555519B2
(en)
|
2000-03-30 |
2003-04-29 |
Bristol-Myers Squibb Company |
O-glucosylated benzamide SGLT2 inhibitors and method
|
|
US6683056B2
(en)
|
2000-03-30 |
2004-01-27 |
Bristol-Myers Squibb Company |
O-aryl glucoside SGLT2 inhibitors and method
|
|
WO2002036602A1
(en)
|
2000-11-02 |
2002-05-10 |
Ajinomoto Co., Inc. |
Novel pyrazole derivatives and diabetes remedies containing the same
|
|
JP4590158B2
(en)
|
2001-04-04 |
2010-12-01 |
オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド |
Combination therapy comprising a glucose reabsorption inhibitor and a retinoid-X receptor modulator
|
|
DK1385856T3
(en)
|
2001-04-11 |
2006-05-15 |
Bristol Myers Squibb Co |
Amino acid complexes of C-aryl glucosides for the treatment of diabetes and methods
|
|
EP1389621A4
(en)
|
2001-04-27 |
2005-05-11 |
Ajinomoto Kk |
N-substituted pyrazolyl-o-glycoside derivatives and remedial agent for diabetes containing the same
|
|
US6801798B2
(en)
|
2001-06-20 |
2004-10-05 |
Purdue Research Foundation |
Body-member-illuminating pressure cuff for use in optical noninvasive measurement of blood parameters
|
|
PL210710B1
(en)
|
2002-03-22 |
2012-02-29 |
Kissei Pharmaceutical |
Crystals of glucopyranosyloxybenzyl benzene derivative
|
|
ATE510834T1
(en)
|
2003-03-14 |
2011-06-15 |
Astellas Pharma Inc |
C-GLYCOSIDE DERIVATIVES FOR TREATING DIABETES
|
|
CN1761676A
(en)
|
2003-04-01 |
2006-04-19 |
大正制药株式会社 |
Heteroaryl 5-thio-beta-d-glucopyranoside derivatives and remedies for diabetes containing the same
|
|
JP2004359630A
(en)
|
2003-06-06 |
2004-12-24 |
Yamanouchi Pharmaceut Co Ltd |
Difluorodiphenylmethane derivatives and their salts
|
|
CN104109155A
(en)
|
2003-08-01 |
2014-10-22 |
田边三菱制药株式会社 |
Novel compounds
|
|
UA86042C2
(en)
|
2003-08-01 |
2009-03-25 |
Янссен Фармацевтика Н.В. |
Substituted indazole-o-glucosides
|
|
US7375090B2
(en)
|
2003-08-26 |
2008-05-20 |
Boehringer Ingelheim International Gmbh |
Glucopyranosyloxy-pyrazoles, pharmaceutical compositions containing these compounds, the use thereof and processed for the preparation thereof
|
|
EA011158B1
(en)
|
2004-03-16 |
2009-02-27 |
Бёрингер Ингельхайм Интернациональ Гмбх |
GLUCOPIRANOZE-SUBSTITUTED BENZENE DERIVATIVES CONTAINING THESE COMPOUNDS MEDICINES, THEIR APPLICATION AND METHOD FOR THEIR PRODUCTION
|
|
US7393836B2
(en)
|
2004-07-06 |
2008-07-01 |
Boehringer Ingelheim International Gmbh |
D-xylopyranosyl-substituted phenyl derivatives, medicaments containing such compounds, their use and process for their manufacture
|
|
DE102004034690A1
(en)
|
2004-07-17 |
2006-02-02 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Methylidene-D-xylopyranosyl and oxo-D-xylopyranosyl-substituted phenyls, medicaments containing these compounds, their use and processes for their preparation
|
|
TW200606129A
(en)
|
2004-07-26 |
2006-02-16 |
Chugai Pharmaceutical Co Ltd |
Novel cyclohexane derivative, its prodrug, its salt and diabetic therapeutic agent containing the same
|
|
WO2006010557A1
(en)
|
2004-07-27 |
2006-02-02 |
Boehringer Ingelheim International Gmbh |
D-glucopyranosyl phenyl-substituted cyclene, medicaments containing these compounds, their use, and method for the production thereof
|
|
WO2006018150A1
(en)
|
2004-08-11 |
2006-02-23 |
Boehringer Ingelheim International Gmbh |
D-xylopyranosyl-phenyl-substituited cyclene, medicaments containing said compounds, use thereof and method for the production thereof
|
|
AR051446A1
(en)
|
2004-09-23 |
2007-01-17 |
Bristol Myers Squibb Co |
C-ARYL GLUCOSIDS AS SELECTIVE INHIBITORS OF GLUCOSE CONVEYORS (SGLT2)
|
|
JP2006117651A
(en)
|
2004-09-27 |
2006-05-11 |
Taisho Pharmaceut Co Ltd |
SGLT2 activity inhibitor
|
|
CA2581922A1
(en)
|
2004-09-29 |
2006-04-06 |
Kissei Pharmaceutical Co., Ltd. |
1-(.beta.-d-glycopyranosyl)-3-substituted nitrogenous heterocyclic compound, medicinal composition containing the same, and medicinal use thereof
|
|
DE102004048388A1
(en)
|
2004-10-01 |
2006-04-06 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
D-pyranosyl-substituted phenyls, pharmaceutical compositions containing them, their use and processes for their preparation
|
|
DE102004058449A1
(en)
|
2004-12-03 |
2006-06-14 |
Merck Patent Gmbh |
tetrahydropyran
|
|
TW200637869A
(en)
|
2005-01-28 |
2006-11-01 |
Chugai Pharmaceutical Co Ltd |
The spiroketal derivatives and the use as therapeutical agent for diabetes of the same
|
|
JP5175191B2
(en)
|
2005-08-30 |
2013-04-03 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
Glycopyranosyl-substituted benzylbenzene derivative, pharmaceutical containing the compound, and use and production method thereof
|
|
AR059489A1
(en)
*
|
2006-02-15 |
2008-04-09 |
Boehringer Ingelheim Vetmed |
BENZONITRILE DERIVATIVES REPLACED WITH GLUCOPYRANOSIL, PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS OF THIS TYPE, USE AND PROCEDURE FOR MANUFACTURING
|
|
US7919598B2
(en)
|
2006-06-28 |
2011-04-05 |
Bristol-Myers Squibb Company |
Crystal structures of SGLT2 inhibitors and processes for preparing same
|
|
US7910747B2
(en)
|
2006-07-06 |
2011-03-22 |
Bristol-Myers Squibb Company |
Phosphonate and phosphinate pyrazolylamide glucokinase activators
|
|
US7569590B2
(en)
|
2006-09-19 |
2009-08-04 |
Bristol-Myers Squibb Company |
Use of thianecarboxamides as dgat inhibitors
|
|
TW200904405A
(en)
|
2007-03-22 |
2009-02-01 |
Bristol Myers Squibb Co |
Pharmaceutical formulations containing an SGLT2 inhibitor
|
|
WO2009143021A1
(en)
|
2008-05-22 |
2009-11-26 |
Bristol-Myers Squibb Company |
Method for treating and preventing kidney stones employing an sglt2 inhibitor and composition containing same
|
|
KR20110118668A
(en)
|
2009-02-13 |
2011-10-31 |
베링거 인겔하임 인터내셔날 게엠베하 |
SVLT2 inhibitors for the treatment of type 1 diabetes, type 2 diabetes, impaired glucose tolerance or hyperglycemia
|
|
MX339194B
(en)
*
|
2009-02-13 |
2016-05-16 |
Boehringer Ingelheim Int |
Pharmaceutical composition comprising a sglt2 inhibitor, a dpp-iv inhibitor and optionally a further antidiabetic agent and uses thereof.
|
|
JP2013523681A
(en)
|
2010-03-30 |
2013-06-17 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
Pharmaceutical composition comprising SGLT2 inhibitor and PPAR-gamma agonist and use thereof
|
|
US20140303097A1
(en)
|
2013-04-05 |
2014-10-09 |
Boehringer Ingelheim International Gmbh |
Pharmaceutical composition, methods for treating and uses thereof
|
|
CA2812016A1
(en)
|
2013-04-05 |
2014-10-05 |
Boehringer Ingelheim International Gmbh |
Pharmaceutical composition, methods for treating and uses thereof
|
|
US9526728B2
(en)
*
|
2014-02-28 |
2016-12-27 |
Boehringer Ingelheim International Gmbh |
Medical use of a DPP-4 inhibitor
|
|
ME03316B
(en)
|
2014-06-30 |
2019-10-20 |
Astrazeneca Ab |
BENZOKSAZINON STARCHES КАО MINERAL MODULATORSOKORТIKOIDNOG RECEPTORA
|
|
EP3735975B1
(en)
|
2016-03-11 |
2025-12-03 |
Merck Sharp & Dohme LLC |
Ertugliflozin for use in treating heart failure in patients with diabetes
|
|
KR20230111262A
(en)
|
2016-03-16 |
2023-07-25 |
베링거 인겔하임 인터내셔날 게엠베하 |
Pharmaceutical composition comprising empagliflozin and uses thereof
|
|
JPWO2018043463A1
(en)
|
2016-08-30 |
2019-06-24 |
国立大学法人 新潟大学 |
Senescent cell removal drug
|
|
WO2018142422A1
(en)
|
2017-02-02 |
2018-08-09 |
Indoco Remedies Limited |
Process for the preparation of dapagliflozin
|
|
KR101943382B1
(en)
|
2017-09-19 |
2019-01-29 |
오토텔릭바이오 주식회사 |
A pharmaceutical composition comprising SGLT-2 inhibitor and angiotensin receptor blocker
|
|
JOP20210009A1
(en)
|
2018-07-19 |
2021-01-12 |
Astrazeneca Ab |
Methods of treating hfpef employing dapagliflozin and compositions comprising the same
|
|
BR112020008705A2
(en)
|
2019-08-30 |
2022-03-22 |
Astrazeneca Ab |
Methods of treating heart failure with reduced ejection fraction with dapagliflozin
|